Natera (NTRA) Company Overview

Description:

Natera, Inc. is a diagnostic company that provides services in the field of reproductive health and genetic disease diagnostics. The company was founded in 2004 and is located in San Carlos, California. The company's main product is Panorama, a non-invasive prenatal test (NIPT) that detects fetal chromosomal abnormalities, including Down syndrome, Edwards syndrome, Patau syndrome, Turner syndrome, and triploidy. It also detects pathologies that often lead to intellectual disabilities, severe organ anomalies, and miscarriage. Panorama can also determine the sex of the fetus in a singleton pregnancy, as well as each fetus in a twin pregnancy. Panorama is also the only commercially available NIPT that can determine whether a set of twins is identical, monozygotic, dizygotic, or trizygotic.